Letters to the Editor: On paying $3,000 for a COVID-19 drug developed with taxpayer funding
Saturday, July 4, 2020 - 05:30
in Mathematics & Economics
Drug companies will undertake expensive research and development only when taxpayers contribute. This is unfair and counterproductive.